Children Nutrition Research Center (Houston, Tx) Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Children's Nutrition Research Center Research
Metabolic Research Unit
Body Composition Lab
Eating Behavior Laboratory
Energy Metabolism Lab
Plant Physiology Lab
Analytical Core Labs
 

Title: SMALL INTESTINAL GROWTH AND LACTASE SYNTHESIS IN NEONATAL PIGS FED FORMULA SUPPLEMENTED WITH IGF-I

Authors
item Burrin, Douglas
item Stoll, Barbara - BAYLOR COLL OF MEDICINE
item Dudley, Mary - BAYLOR COLL OF MEDICINE
item Reeds, Peter - BAYLOR COLL OF MEDICINE
item Donovan, Sharon - UNIVERSITY OF ILLINOIS
item Fan, Ming

Submitted to: Federation of American Societies for Experimental Biology Conference
Publication Type: Abstract Only
Publication Acceptance Date: March 1, 1998
Publication Date: N/A

Interpretive Summary: Interpretive Summary not needed for this 115.

Technical Abstract: Previous studies with cesarean-derived, colostrum-deprived neonatal pigs have shown that oral IGF-I increases intestinal lactase activity at physiological doses, and mucosal protein and DNA mass at pharmacological doses. To establish the mechanism of these dose-dependent responses, we determined the effect of oral IGF-I on intestinal protein synthesis, lactase processing and crypt cell proliferation. One-day-old, vaginally delivered, colostrum-fed pigs were fed (1) formula (n=5), (2) formula + low IGF-I (0.5mg/L;n=6), or (3) formula + high IGF-I (12.0mg/L;n=6) for 14 d. Pigs were fed 300-350 mL/kg body weight daily. On d 15, intestinal protein synthesis and lactase processing were measured in the fed state using an intravenous multiple stable isotope infusion of 2H3-Leu, 13C1-Leu, 2H5-Phe, 13C6-Phe, and 13C9-Phe for 6 h. Cell proliferation was measured using an intraarterial injection of BrdU 2 h prior to killing. In contrast to previous studies, no effect of IGF-I was observed on intestinal weight, protein, DNA content, or lactase and sucrase activities. It is possible that (1) either the process of vaginal birth or colostrum ingestion may negate the effects of IGF-I, (2) the anabolic effects of IGF-I occur only during the early neonatal period, or (3) the increases in enzyme activity are only detectable in the postabsorptive state.

   
 
 
Last Modified: 05/25/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House